The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price decrease of -69.73%. However, over the past six months, we’ve seen a stronger performance of -56.21%. The price of PSTV fallen by 68.19% over the last 30 days. And in the last five days, it has surged by 42.61%.
Currently, the stock price of Plus Therapeutics Inc (PSTV) is $0.53. In the most recent trading session, the stock underwent a significant upswing, peaking at $20.5 after opening at $0.53. The stock touched a low of $3.0 before closing at $0.6.
In terms of market performance, Plus Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $2.31 on 03/07/25, while the lowest value was $0.16 on 06/18/25.
52-week price history of PSTV Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Plus Therapeutics Inc’s current trading price is -77.06% away from its 52-week high, while its distance from the 52-week low is 224.24%. The stock’s price range over this timeframe has been between $0.16 and $2.31. The shares of the Healthcare sector company recorded a trading volume of approximately 12.97 million for the day, which was comparatively lower than the average daily volume of 28.3 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Plus Therapeutics Inc (PSTV) has experienced a quarterly decline of -37.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 32.05M and boasts a workforce of 21 employees.
Expert Opinions: Analysts’ Ratings for Plus Therapeutics Inc
As of right now, 1 analyst is rating Plus Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6009, with a change in price of -0.1302. Similarly, Plus Therapeutics Inc recorded 28,084,342 in trading volume during the last 100 days, posting a change of -19.73%.
PSTV Stock Stochastic Average
Plus Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 62.91%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 59.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 72.64% and 81.44%, respectively.
